Search results
US FDA approves Moderna's RSV vaccine with lower-than-expected efficacy in its label
Reuters· 5 days ago, opens new tab respiratory syncytial virus (RSV) vaccine, the company announced on Friday, giving...
FDA approves Moderna’s RSV vaccine mRESVIA
Pharmaceutical Technology via Yahoo Finance· 3 days agoModerna has secured approval from the US Food and Drug Administration (FDA) for its mRNA-based respiratory syncytial virus (RSV) vaccine mRESVIA...
Study shows new cancer vaccine to treat melanoma has 96% survival rate
UNILAD· 1 day agoA new vaccine treatment for skin cancer melanoma has shown extremely promising results in a new...
Moderna (MRNA) Secures FDA Nod for mRNA-Based RSV Vaccine
Zacks· 3 days agoThe RSV vaccine is Moderna???s (MRNA) second FDA-approved product. Once the vaccine secures the CDC's recommendation, it will be launched in the 2024-2025 respiratory virus season.
Moderna, Merck say vaccine improved survival in patients with deadly skin cancer
CNBC· 2 days agoModerna and Merck released more positive three-year data Monday on their experimental vaccine, given...
RBC Capital lifts Moderna shares target, highlights RSV vaccine approval By Investing.com
Investing.com· 2 days agoModerna (NASDAQ:MRNA) shares, raising the price target to $160 from the previous $135 while...
Moderna's RSV vaccine for older adults approved
Axios· 5 days agoWhy it matters: It's Moderna's second approved product, and company officials said it's the first mRNA vaccine approved for a disease other than COVID-19...
Promising Trial Results Show New Standards In Cancer Treatment And Diagnostics Are On The Horizon
Benzinga via Yahoo Finance· 1 day agoOn Monday, Moderna (NASDAQ: MRNA) and Merck & Co (NYSE: MRK) also reported durable efficiency of...
Moderna Looks for Boost From Newly Approved RSV Shot
The Wall Street Journal· 5 days agoThe U.S. Food and Drug Administration approved Moderna’s vaccine to protect against respiratory syncytial virus, or RSV, a common virus that is among the...
How Moderna’s newly approved RSV vaccine could impact 2024 revenue - Boston Business Journal
The Business Journals· 2 days agoThe RSV vaccine will now be reviewed at the CDC's Advisory Committee on Immunization Practices...